Development of an in-house 188W/188Re generator
Research output: Contribution to report/book/conference proceedings › In-proceedings paper
Institutes & Expert groups
- KUL - Katholieke Universiteit Leuven
Documents & links
DOI
Abstract
188Re decays by emitting high-energy beta particles (Emax: 2.1 MeV, Eav: 784 keV), which can be used to kill targeted tumor cells. The short half-life (t1/2 = 16.9 h) of 188Re allows it to be used in targeted radionuclide therapy when linked to peptides or antibodies. 188Re decays with a 155 keV (15%) gamma emission suitable for imaging and dosimetry. Combining these properties make 188Re an ideal theranostic agent in clinical nuclear medicine. Furthermore, 188Re is readily available from a 188W/188Re generator which enables the use of nca 188Re in hospitals and remote locations [1].
Details
| Original language | English |
|---|---|
| Title of host publication | European Journal of Nuclear Medicine and Molecular Imaging |
| Pages | 477 |
| Number of pages | 478 |
| Volume | 47 |
| Edition | suppl. 1 |
| DOIs | |
| Publication status | Published - 30 Oct 2020 |
Publication series
| Name | European Journal of Nuclear Medicine and Molecular Imaging |
|---|---|
| Publisher | Springer |
| Number | Supplement 1 |
| Volume | 47 |
| ISSN (Print) | 1619-7070 |
Keywords
- 188W/188Re generator, radiolabeling, chelator, in house
ID: 7071702